Analysts revise ratings and price targets for US-listed companies
Analysts revised ratings and price targets for several US-listed companies, including Eli Lilly, General Dynamics and S&P Global.
Analysts revised ratings and price targets for several US-listed companies, including Eli Lilly, General Dynamics and S&P Global.